Roche Competitors and Similar CompaniesClear all

Agilent Technologies's competitors and similar companies include Thermo Fisher Scientific, Leica Biosystems Nussloch, Dexcom, GSK, Amgen, Johnson & Johnson, Bayer, Abbott, Danaher, Pfizer and BD.
Agilent Technologies
Agilent Technologies
Agilent Technologies is a company that designs and manufactures laboratory instruments.
Thermo Fisher Scientific
Thermo Fisher Scientific
Thermo Fisher Scientific is a biotechnology company engaged in service science.
Leica Biosystems Nussloch
Leica Biosystems Nussloch
Leica Biosystems Nussloch is a medical device company that develops cancer diagnostic products.
Dexcom
Dexcom
Dexcom is a company that specializes in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes.
GSK
GSK
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
Bayer
Bayer
Bayer is a life sciences company specializing in healthcare and nutrition.
Abbott
Abbott
Abbott Laboratories is a company that specializes in the discovery, development, manufacture, and sale of healthcare products.
Danaher
Danaher
Danaher (formerly known as Diversified Mortgage Investors) is a company that develops and manufactures molecular diagnostics and therapeutics products.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
BD
BD
BD (Becton, Dickinson and Company) is a medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products.
Founding Date
Founding Date
1999
Founding Date
1956
Founding Date
1989
Founding Date
1999
Founding Date
2000
Founding Date
1980
Founding Date
1886
Founding Date
1863
Founding Date
1894
Founding Date
1984
Founding Date
1849
Founding Date
1897
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Santa Clara, US HQ
Belmont, AU
Chatswood, AU
Thomastown, AU
Victoria, AU
Wien, AT
Heverlee, BE
see more
Locations
Waltham, US HQ
Buenos Aires, AR
Buenos Aires, AR
Buenos Aires, AR
Adelaide Airport, AU
Brendale, AU
Canberra, AU
see more
Locations
Nußloch, DE HQ
Mumbai, IN
Buffalo Grove, US
Deer Park, US
Locations
San Diego, US HQ
Brunn Am Gebirge, AT
Burnaby, CA
Mainz, DE
Horw, CH
Camberley, GB
Locations
London, GB HQ
Boumerdes, DZ
Buenos Aires, AR
Abbotsford, AU
Wien, AT
Wavre, BE
Rio De Janeiro, BR
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Diegem, BE
Santo Amaro, BR
see more
Locations
New Brunswick, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
Minsk, BY
Beerse, BE
Sofia, BG
see more
Locations
Leverkusen, DE HQ
Tirana, AL
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
see more
Locations
Abbott Park, US HQ
Tiranë, AL
Buenos Aires, AR
Yerevan, AM
Doncaster, AU
East Brisbane, AU
Macquarie Park, AU
see more
Locations
Washington, US HQ
Mount Waverley, AU
Vienna, AT
Ghent, BE
Sao Paolo, BR
Vancouver, CA
Shanghai, CN
see more
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Footscray, AU
Mulgrave, AU
Sydney, AU
Wien, AT
see more
Locations
Franklin Lakes, US HQ
Vicente López, AR
Frenchs Forest, AU
Macquarie Park, AU
Seven Hills, AU
Schwechat, AT
Wien, AT
see more
Employees
Employees
17,9001% decrease
Employees
125,0002% increase
Employees
38918% increase
Employees
9,50027% increase
Employees
68,629
Employees
25,200
Employees
131,90014% decrease
Employees
92,8152% decrease
Employees
114,000
Employees
61,000
Employees
88,0006% increase
Employees
73,0005% decrease
Valuation ($)
Valuation ($)
37.7 b
Valuation ($)
209.2 b
Valuation ($)
N/A
Valuation ($)
28.2 b
Valuation ($)
862.5 m
Valuation ($)
170.4 b
Valuation ($)
396.3 b
Valuation ($)
27.1 b
Valuation ($)
196.1 b
Valuation ($)
175.3 b
Valuation ($)
163.9 b
Valuation ($)
68.7 b

Financial

Revenue (est.)
Revenue (est.)
$6.5b (FY, 2024)
Revenue (est.)
$42.9b (FY, 2024)
Revenue (est.)
$254.8m (FY, 2022)
Revenue (est.)
$4b (FY, 2024)
Revenue (est.)
£31.4b (FY, 2024)
Revenue (est.)
$33.4b (FY, 2024)
Revenue (est.)
$88.8b (FY, 2024)
Revenue (est.)
€46.6b (FY, 2024)
Revenue (est.)
$42b (FY, 2024)
Revenue (est.)
$23.9b (FY, 2024)
Revenue (est.)
$63.6b (FY, 2024)
Revenue (est.)
$20.2b (FY, 2024)
Cost of goods
Cost of goods
$3b (FY, 2024)
Cost of goods
$25.2b (FY, 2024)
Cost of goods
$154.7m (FY, 2022)
Cost of goods
$1.6b (FY, 2024)
Cost of goods
£6.1b (FY, 2024)
Cost of goods
$12.9b (FY, 2024)
Cost of goods
$27.5b (FY, 2024)
Cost of goods
€12b (FY, 2024)
Cost of goods
$18.7b (FY, 2024)
Cost of goods
$9.7b (FY, 2024)
Cost of goods
$17.9b (FY, 2024)
Cost of goods
$11.1b (FY, 2024)
Gross profit
Gross profit
$3.5b (FY, 2024)
Gross profit
$17.7b (FY, 2024)
Gross profit
$100.1m (FY, 2022)
Gross profit
$2.4b (FY, 2024)
Gross profit
£25.9b (FY, 2024)
Gross profit
$20.6b (FY, 2024)
Gross profit
$61.4b (FY, 2024)
Gross profit
€35.8b (FY, 2024)
Gross profit
$23.2b (FY, 2024)
Gross profit
$14.2b (FY, 2024)
Gross profit
$45.8b (FY, 2024)
Gross profit
$9.1b (FY, 2024)
Net income
Net income
$1.3b (FY, 2024)
Net income
$6.3b (FY, 2024)
Net income
$32.6m (FY, 2022)
Net income
$576.2m (FY, 2024)
Net income
£3b (FY, 2024)
Net income
$4.1b (FY, 2024)
Net income
$14.1b (FY, 2024)
Net income
(€2.5b) (FY, 2024)
Net income
$13.4b (FY, 2024)
Net income
$3.9b (FY, 2024)
Net income
$8.1b (FY, 2024)
Net income
$1.7b (FY, 2024)

Operating

Business Segments
Business Segments
N/A
Business Segments
N/A
Business Segments
N/A
Business Segments
N/A
Business Segments
N/A
Business Segments
N/A
Business Segments
N/A
Business Segments
N/A
Business Segments
N/A
Business Segments
4 (FY, 2023)
Business Segments
N/A
Business Segments
3 (FY, 2023)
Countries
Countries
N/A
Countries
70 (FY, 2023)
Countries
35 (Feb, 2024)
Countries
N/A
Countries
92 (FY, 2021)
Countries
100 (FY, 2020)
Countries
N/A
Countries
83 (FY, 2021)
Countries
N/A
Countries
50 (FY, 2023)
Countries
125 (FY, 2021)
Countries
N/A
Facilities
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
180 (FY, 2020)
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
184 (FY, 2023)
Facilities
N/A
Facilities
N/A
Facility Space Leased, sq. ft.
Facility Space Leased, sq. ft.
1.9 m (FY, 2023)
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
N/A
Facility Space Leased, sq. ft.
8 m (FY, 2023)
Facility Space Owned, sq. ft.
Facility Space Owned, sq. ft.
4.9 m (FY, 2023)
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
N/A
Facility Space Owned, sq. ft.
18.1 m (FY, 2023)
Facility Space, sq. ft.
Facility Space, sq. ft.
6.8 m (FY, 2023)
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
44 m (FY, 2023)
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
N/A
Facility Space, sq. ft.
N/A
Manufacturing Sites
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
6 (Feb, 2024)
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
39 (FY, 2021)
Manufacturing Sites
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
16 (FY, 2021)
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
27 (FY, 2021)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
6 (FY, 2021)
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
25 (FY, 2021)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
11 (FY, 2021)
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
27 (FY, 2021)
Phase III Trials Products
N/A
Remaining Performance Obligations
Remaining Performance Obligations
N/A
Remaining Performance Obligations
$25.3b (Q3, 2024)
Remaining Performance Obligations
N/A
Remaining Performance Obligations
N/A
Remaining Performance Obligations
N/A
Remaining Performance Obligations
N/A
Remaining Performance Obligations
N/A
Remaining Performance Obligations
N/A
Remaining Performance Obligations
N/A
Remaining Performance Obligations
$4.5b (Q2, 2024)
Remaining Performance Obligations
N/A
Remaining Performance Obligations
N/A
Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
37.5 k (FY, 2021)
Suppliers
N/A
Suppliers
N/A
Suppliers
93.8 k (FY, 2021)
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Trademarks
Trademarks
N/A
Trademarks
N/A
Trademarks
170 (Feb, 2024)
Trademarks
N/A
Trademarks
N/A
Trademarks
N/A
Trademarks
N/A
Trademarks
1.5 k (FY, 2021)
Trademarks
N/A
Trademarks
N/A
Trademarks
N/A
Trademarks
N/A
Trademarks Pending
Trademarks Pending
N/A
Trademarks Pending
N/A
Trademarks Pending
3 (Feb, 2024)
Trademarks Pending
N/A
Trademarks Pending
N/A
Trademarks Pending
N/A
Trademarks Pending
N/A
Trademarks Pending
74 (FY, 2021)
Trademarks Pending
N/A
Trademarks Pending
N/A
Trademarks Pending
N/A
Trademarks Pending
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 500m
Total funding raised
N/A
Total funding raised
$ 2.7b
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 3.5b
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Thermo Fisher Scientific
HQ
Waltham, US
Employees
125,000↑ 2% increase

Thermo Fisher Scientific is a biotechnology company engaged in service science.

View company
Leica Biosystems Nussloch
HQ
Nußloch, DE

Leica Biosystems Nussloch is a medical device company that develops cancer diagnostic products.

View company
Dexcom
HQ
San Diego, US
Employees
9,500↑ 27% increase

Dexcom is a company that specializes in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes.

View company
GSK
HQ
London, GB
Employees
68,629

GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.

View company